Fine Organic Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 4, 2025, 12:13 pm

Competitors of Fine Organic Industries Ltd

All Competitor Stocks of Fine Organic Industries Ltd

Quarterly Result

Last Updated: February 28, 2025, 8:45 pm

Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is ₹513.00 Cr.. The value appears to be declining and may need further review. It has decreased from 596.00 Cr. (Sep 2024) to ₹513.00 Cr., marking a decrease of 83.00 Cr..
• For Expenses, as of Dec 2024, the value is ₹414.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 446.00 Cr. (Sep 2024) to ₹414.00 Cr., marking a decrease of 32.00 Cr..
• For Operating Profit, as of Dec 2024, the value is ₹99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Sep 2024) to ₹99.00 Cr., marking a decrease of 51.00 Cr..
• For OPM %, as of Dec 2024, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Sep 2024) to 19.00%, marking a decrease of 6.00%.
• For Other Income, as of Dec 2024, the value is ₹29.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Sep 2024) to ₹29.00 Cr., marking an increase of 7.00 Cr..
• For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Sep 2024) to ₹13.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Dec 2024, the value is ₹115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Sep 2024) to ₹115.00 Cr., marking a decrease of 44.00 Cr..
• For Tax %, as of Dec 2024, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Sep 2024) to 28.00%, marking an increase of 2.00%.
• For Net Profit, as of Dec 2024, the value is ₹83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 117.00 Cr. (Sep 2024) to ₹83.00 Cr., marking a decrease of 34.00 Cr..
• For EPS in Rs, as of Dec 2024, the value is 26.97. The value appears to be declining and may need further review. It has decreased from 38.30 (Sep 2024) to 26.97, marking a decrease of 11.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:27 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:49 am

Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹2,105.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,906.00 Cr. (Mar 2024) to ₹2,105.00 Cr., marking an increase of 199.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹4.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹224.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.00 Cr. (Mar 2024) to ₹224.00 Cr., marking an increase of 42.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹2,347.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,108.00 Cr. (Mar 2024) to ₹2,347.00 Cr., marking an increase of 239.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 233.00 Cr. (Mar 2024) to ₹223.00 Cr., marking a decrease of 10.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to ₹28.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Sep 2024, the value is ₹35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to ₹35.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹2,060.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,809.00 Cr. (Mar 2024) to ₹2,060.00 Cr., marking an increase of 251.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹2,347.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,108.00 Cr. (Mar 2024) to ₹2,347.00 Cr., marking an increase of 239.00 Cr..

Notably, the Reserves (2,105.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For Diluted EPS (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For Cash EPS (Rs.), as of Mar 24, the value is 153.52. This value is within the healthy range. It has decreased from 217.80 (Mar 23) to 153.52, marking a decrease of 64.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 626.57. It has increased from 502.69 (Mar 23) to 626.57, marking an increase of 123.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 626.57. It has increased from 502.69 (Mar 23) to 626.57, marking an increase of 123.88.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 692.42. It has decreased from 986.00 (Mar 23) to 692.42, marking a decrease of 293.58.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 197.62. This value is within the healthy range. It has decreased from 291.99 (Mar 23) to 197.62, marking a decrease of 94.37.
• For PBIT / Share (Rs.), as of Mar 24, the value is 179.31. This value is within the healthy range. It has decreased from 276.37 (Mar 23) to 179.31, marking a decrease of 97.06.
• For PBT / Share (Rs.), as of Mar 24, the value is 178.33. This value is within the healthy range. It has decreased from 274.88 (Mar 23) to 178.33, marking a decrease of 96.55.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 135.20. This value is within the healthy range. It has decreased from 202.18 (Mar 23) to 135.20, marking a decrease of 66.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For PBDIT Margin (%), as of Mar 24, the value is 28.54. This value is within the healthy range. It has decreased from 29.61 (Mar 23) to 28.54, marking a decrease of 1.07.
• For PBIT Margin (%), as of Mar 24, the value is 25.89. This value exceeds the healthy maximum of 20. It has decreased from 28.02 (Mar 23) to 25.89, marking a decrease of 2.13.
• For PBT Margin (%), as of Mar 24, the value is 25.75. This value is within the healthy range. It has decreased from 27.87 (Mar 23) to 25.75, marking a decrease of 2.12.
• For Net Profit Margin (%), as of Mar 24, the value is 19.52. This value exceeds the healthy maximum of 10. It has decreased from 20.50 (Mar 23) to 19.52, marking a decrease of 0.98.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 19.40. This value is within the healthy range. It has decreased from 20.44 (Mar 23) to 19.40, marking a decrease of 1.04.
• For Return on Networth / Equity (%), as of Mar 24, the value is 21.44. This value is within the healthy range. It has decreased from 40.10 (Mar 23) to 21.44, marking a decrease of 18.66.
• For Return on Capital Employeed (%), as of Mar 24, the value is 28.58. This value is within the healthy range. It has decreased from 54.94 (Mar 23) to 28.58, marking a decrease of 26.36.
• For Return On Assets (%), as of Mar 24, the value is 19.54. This value is within the healthy range. It has decreased from 34.21 (Mar 23) to 19.54, marking a decrease of 14.67.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.08. It has decreased from 2.01 (Mar 23) to 1.08, marking a decrease of 0.93.
• For Current Ratio (X), as of Mar 24, the value is 9.13. This value exceeds the healthy maximum of 3. It has increased from 5.37 (Mar 23) to 9.13, marking an increase of 3.76.
• For Quick Ratio (X), as of Mar 24, the value is 7.71. This value exceeds the healthy maximum of 2. It has increased from 3.68 (Mar 23) to 7.71, marking an increase of 4.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.07. This value is below the healthy minimum of 4. It has decreased from 7.20 (Mar 23) to 3.07, marking a decrease of 4.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.69. This value is below the healthy minimum of 20. It has increased from 4.46 (Mar 23) to 6.69, marking an increase of 2.23.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.89. This value is below the healthy minimum of 20. It has increased from 4.14 (Mar 23) to 5.89, marking an increase of 1.75.
• For Earning Retention Ratio (%), as of Mar 24, the value is 93.31. This value exceeds the healthy maximum of 70. It has decreased from 95.54 (Mar 23) to 93.31, marking a decrease of 2.23.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.11. This value exceeds the healthy maximum of 70. It has decreased from 95.86 (Mar 23) to 94.11, marking a decrease of 1.75.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 249.04. This value is within the healthy range. It has increased from 195.73 (Mar 23) to 249.04, marking an increase of 53.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 171.61. This value is within the healthy range. It has increased from 136.52 (Mar 23) to 171.61, marking an increase of 35.09.
• For Enterprise Value (Cr.), as of Mar 24, the value is 11,309.92. It has decreased from 12,708.88 (Mar 23) to 11,309.92, marking a decrease of 1,398.96.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.33. This value exceeds the healthy maximum of 3. It has increased from 4.20 (Mar 23) to 5.33, marking an increase of 1.13.
• For EV / EBITDA (X), as of Mar 24, the value is 18.67. This value exceeds the healthy maximum of 15. It has increased from 14.20 (Mar 23) to 18.67, marking an increase of 4.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.82. This value exceeds the healthy maximum of 3. It has increased from 4.37 (Mar 23) to 5.82, marking an increase of 1.45.
• For Retention Ratios (%), as of Mar 24, the value is 93.30. This value exceeds the healthy maximum of 70. It has decreased from 95.53 (Mar 23) to 93.30, marking a decrease of 2.23.
• For Price / BV (X), as of Mar 24, the value is 6.43. This value exceeds the healthy maximum of 3. It has decreased from 8.57 (Mar 23) to 6.43, marking a decrease of 2.14.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.82. This value exceeds the healthy maximum of 3. It has increased from 4.37 (Mar 23) to 5.82, marking an increase of 1.45.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness